Showing results (771-780 of 798) with videos related to
Sort By:
Pageof 80
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.Nano Letters|February 2, 2017
Engineering the Structural and Electronic Phases of MoTe<sub>2</sub> through W SubstitutionD Rhodes, D A Chenet, B E Janicek, et al.Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.Lancet (London, England)|September 30, 2017
Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline analysis for the Sustainable Development GoalsNick Golding, Roy Burstein, Joshua Longbottom, et al.Journal of Medicinal Chemistry|November 11, 2014
Discovery of AM-7209, a potent and selective 4-amidobenzoic acid inhibitor of the MDM2-p53 interactionYosup Rew, Daqing Sun, Xuelei Yan, et al.Journal of Medicinal Chemistry|April 25, 2012
Structure-based design of novel inhibitors of the MDM2-p53 interactionYosup Rew, Daqing Sun, Felix Gonzalez-Lopez De Turiso, et al.Nature|November 1, 2019
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunityJude Canon, Karen Rex, Anne Y Saiki, et al.Journal of Medicinal Chemistry|February 20, 2014
Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interactionAna Z Gonzalez, John Eksterowicz, Michael D Bartberger, et al.The New England Journal of Medicine|September 20, 2018
Variation in Childhood Diarrheal Morbidity and Mortality in Africa, 2000-2015Robert C Reiner, Nicholas Graetz, Daniel C Casey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.Pageof 80